Why venetoclax is a promising new drug for CLL
Novel treatments of AML in elderly patients
Treating indolent and mantle cell lymphoma: results of the BRIGHT 5 year follow up study
Midostaurin: a step forward in the treatment of FLT3-mutated AML
How do targeted treatments for IDH1 and IDH2 mutations work in acute myeloid leukemia (AML)?